BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 33142915)

  • 1. Platelets, Thrombocytosis, and Ovarian Cancer Prognosis: Surveying the Landscape of the Literature.
    Hufnagel DH; Cozzi GD; Crispens MA; Beeghly-Fadiel A
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thresholds and timing of pre-operative thrombocytosis and ovarian cancer survival: analysis of laboratory measures from electronic medical records.
    Cozzi GD; Samuel JM; Fromal JT; Keene S; Crispens MA; Khabele D; Beeghly-Fadiel A
    BMC Cancer; 2016 Aug; 16():612. PubMed ID: 27502272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative elevated platelet count and thrombocytosis in gynecologic malignancies.
    Menczer J
    Arch Gynecol Obstet; 2017 Jan; 295(1):9-15. PubMed ID: 27714462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet effects on ovarian cancer.
    Davis AN; Afshar-Kharghan V; Sood AK
    Semin Oncol; 2014 Jun; 41(3):378-84. PubMed ID: 25023353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical relevance of reactive thrombocytosis in patients with ovarian cancer].
    Zeimet AG; Marth C; Müllner-Holzner E; Abfalter E; Daxenbichler G; Dapunt O
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():217-8. PubMed ID: 8118277
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients.
    Feng Z; Wen H; Bi R; Duan Y; Yang W; Wu X
    BMC Cancer; 2016 Jan; 16():43. PubMed ID: 26817451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of thrombocytosis in ovarian cancer.
    Słabuszewska-Jóźwiak A; Dmoch-Gajzlerska E; Kozakiewicz B; Jakiel G
    Ann Agric Environ Med; 2015; 22(4):731-5. PubMed ID: 26706987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombocytosis at secondary cytoreduction for recurrent ovarian cancer predicts suboptimal resection and poor survival.
    Cohen JG; Tran AQ; Rimel BJ; Cass I; Walsh CS; Karlan BY; Li AJ
    Gynecol Oncol; 2014 Mar; 132(3):556-9. PubMed ID: 24423879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of preoperative anemia, leukocytosis and thrombocytosis in chinese women with epithelial ovarian cancer.
    Chen Y; Zhang L; Liu WX; Liu XY
    Asian Pac J Cancer Prev; 2015; 16(3):933-9. PubMed ID: 25735385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors.
    Gungor T; Kanat-Pektas M; Sucak A; Mollamahmutoglu L
    Arch Gynecol Obstet; 2009 Jan; 279(1):53-6. PubMed ID: 18470520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraneoplastic thrombocytosis in ovarian cancer.
    Stone RL; Nick AM; McNeish IA; Balkwill F; Han HD; Bottsford-Miller J; Rupairmoole R; Armaiz-Pena GN; Pecot CV; Coward J; Deavers MT; Vasquez HG; Urbauer D; Landen CN; Hu W; Gershenson H; Matsuo K; Shahzad MM; King ER; Tekedereli I; Ozpolat B; Ahn EH; Bond VK; Wang R; Drew AF; Gushiken F; Lamkin D; Collins K; DeGeest K; Lutgendorf SK; Chiu W; Lopez-Berestein G; Afshar-Kharghan V; Sood AK
    N Engl J Med; 2012 Feb; 366(7):610-8. PubMed ID: 22335738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombocytosis as a prognostic factor in inflammatory breast cancer.
    Harano K; Kogawa T; Wu J; Yuan Y; Cohen EN; Lim B; Reuben JM; Ueno NT
    Breast Cancer Res Treat; 2017 Dec; 166(3):819-832. PubMed ID: 28831670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelets are not hyperreactive in patients with ovarian cancer.
    Feng S; Kroll MH; Nick AM; Sood AK; Afshar-Kharghan V
    Platelets; 2016 Nov; 27(7):716-718. PubMed ID: 27185008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood Platelet Count at Hospital Admission Impacts Long-Term Mortality in Patients with Acute Coronary Syndrome.
    Małyszczak A; Łukawska A; Dyląg I; Lis W; Mysiak A; Kuliczkowski W
    Cardiology; 2020; 145(3):148-154. PubMed ID: 32018251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-platelet interaction in solid tumors.
    Buergy D; Wenz F; Groden C; Brockmann MA
    Int J Cancer; 2012 Jun; 130(12):2747-60. PubMed ID: 22261860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of thrombocytosis in patients with epithelial ovarian cancer.
    Zeimet AG; Marth C; Müller-Holzner E; Daxenbichler G; Dapunt O
    Am J Obstet Gynecol; 1994 Feb; 170(2):549-54. PubMed ID: 8116711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of preoperative thrombocytosis in epithelial ovarian cancer.
    Crasta JA; Premlatha TS; Krishnan SM; Vallikad E; Rameshkumar K
    Indian J Pathol Microbiol; 2010; 53(1):54-6. PubMed ID: 20090223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet Count After Chemotherapy is a Predictor for Outcome for Ovarian Cancer Patients.
    Eggemann H; Ehricke J; Ignatov T; Fettke F; Semczuk A; Costa SD; Ignatov A
    Cancer Invest; 2015 May; 33(5):193-6. PubMed ID: 25831456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombocytosis associated with malignant ovarian lesions within a pediatric/adolescent population.
    Haddad LB; Laufer MR
    J Pediatr Adolesc Gynecol; 2008 Oct; 21(5):243-6. PubMed ID: 18794018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reciprocal links between venous thromboembolism, coagulation factors and ovarian cancer progression.
    Swier N; Versteeg HH
    Thromb Res; 2017 Feb; 150():8-18. PubMed ID: 27988375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.